TrialJAMA network open2024

Riluzole for Degenerative Cervical Myelopathy: A Secondary Analysis of the CSM-PROTECT Trial.

Michael G Fehlings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.